Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.

PubWeight™: 0.78^‹?›

🔗 View Article (PMID 26228246)

Published in Cardiovasc Intervent Radiol on July 31, 2015

Authors

Cheng William Hong¹^,2, Lucy Chow³^,4, Evrim B Turkbey⁵, Riccardo Lencioni⁶, Steven K Libutti⁷^,8, Bradford J Wood⁹^,10^,11

Author Affiliations

1: Center for Interventional Oncology, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1182, Bethesda, MD, 20892, USA. williamhongcheng@gmail.com.
2: Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1074, Bethesda, MD, 20892, USA. williamhongcheng@gmail.com.
3: Center for Interventional Oncology, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1182, Bethesda, MD, 20892, USA. lucychow282@gmail.com.
4: Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1074, Bethesda, MD, 20892, USA. lucychow282@gmail.com.
5: Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1074, Bethesda, MD, 20892, USA. evrimbengi@yahoo.com.
6: Division of Diagnostic Imaging and Intervention, Department of Hepatology and Liver Transplantation, Pisa University Hospital, Via Paradisa 2, Building No. 29, 56124, Pisa, Italy. riccardo.lencioni@med.unipi.it.
7: Montefiore-Einstein Center for Cancer Care, Department of Surgery, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA. slibutti@montefiore.org.
8: National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, GB 9609 MSC 9760, Bethesda, MD, 20892, USA. slibutti@montefiore.org.
9: Center for Interventional Oncology, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1182, Bethesda, MD, 20892, USA. bwood@nih.gov.
10: Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1074, Bethesda, MD, 20892, USA. bwood@nih.gov.
11: National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, GB 9609 MSC 9760, Bethesda, MD, 20892, USA. bwood@nih.gov.

Articles citing this ↘

Analysis of iodinated contrast delivered during thermal ablation: is material trapped in the ablation zone? Phys Med Biol (2016) 0.77

Articles cited by this ↗

Tumor ablation with radio-frequency energy. Radiology (2000) 4.79

Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol (2000) 4.14

Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg (2005) 3.02

Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol (2010) 2.51

Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29

Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg (2007) 2.28

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology (1997) 2.27

Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06

Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol (2005) 1.94

Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol (2005) 1.57

Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology (2001) 1.43

Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol (2006) 1.19

Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia (2010) 1.14

Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg (2008) 1.13

Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging (2000) 1.07

Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Am J Gastroenterol (2009) 0.96

Resection or ablation of small hepatocellular carcinoma: what is the better treatment? J Hepatol (2008) 0.94

Post-treatment imaging of liver tumours. Cancer Imaging (2007) 0.89

Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma. Curr Oncol (2013) 0.84

Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int (2010) 0.83

Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Curr Probl Diagn Radiol (2002) 0.80